
Tirzepatide: GLP-1/GIP
Tirzepatide is a dual-action peptide that acts on GLP-1 and GIP receptors. As part of a comprehensive, physician-supervised plan it may support appetite regulation, blood sugar control, and weight management. Compounded tirzepatide is prescribed following an individualized physician evaluation.
$399
Benefits of Tirzepatide
- May support weight management when combined with lifestyle changes
- May help with appetite and food cravings
- May support insulin sensitivity and blood sugar regulation
- May support metabolic health
Usage Guidance
- Cycle length: Typically prescribed in ongoing weekly injections, with dosing adjusted gradually
- Dosing: Individualized by your provider to maximize effectiveness while minimizing side effects
- Stacking: Sometimes combined with lifestyle interventions such as nutrition support, exercise programs, and other peptides to enhance results
Who It May Help
- Adults seeking medical support for weight loss or weight maintenance
- People with obesity or overweight struggling to lose weight through diet and exercise alone
- Individuals with insulin resistance or metabolic concerns
- Patients seeking to improve energy, mobility, and long-term health outcomes
What to Expect
- Many patients notice appetite changes within the first weeks
- Results typically build over several months as dosing progresses
- Common experiences include smaller meal portions, steadier energy, and gradual changes in weight
- Works well when paired with long-term lifestyle changes like balanced nutrition and regular physical activity
Important Information
Compounded medications are not FDA-approved. They are prepared by appropriately licensed U.S. compounding pharmacies pursuant to a valid, patient-specific prescription when determined medically appropriate by the treating physician. Compounded tirzepatide is prescribed following an individualized physician evaluation, and individual results vary.

.avif)